---
figid: PMC8674309__fimmu-12-782852-g001
figtitle: 'Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation
  of Interferon Pathway in the Tumor Microenvironment'
organisms:
- Hepatitis B virus
- Human gammaherpesvirus 4
- Adenoviridae
- Human alphaherpesvirus 1
- Human papillomavirus
- unidentified influenza virus
- Mouse mammary tumor virus
- Human papillomavirus type 16
- Human betaherpesvirus 5
- Human gammaherpesvirus 8
- Zika virus
- Human T-cell leukemia virus type I
- Reovirus sp.
- Polyomavirus sp.
- Merkel cell polyomavirus
- Human endogenous retroviruses
- Human endogenous retrovirus
- Human endogenous retrovirus K
- Senecavirus A
- Mouse papillomavirus 1
- Mus musculus
- Spalacinae
- Homo sapiens
- Canis lupus familiaris
- transposons
- NA
- NA
organisms_ner:
- Canis lupus familiaris
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC8674309
filename: fimmu-12-782852-g001.jpg
figlink: /pmc/articles/PMC8674309/figure/f1/
number: F1
caption: Activation of IFN-I/III response by viral sensing through PRRs. Sensing of
  viral molecules by plasma membrane (TRL4), endosomal (TLR3, 7, 8 and 9) or cytosolic
  (RLRs and cGAS) PRRs activate signaling pathways culminating in the expression of
  pro-inflammatory cytokines (IL-1β, IL-6, IL-18 and TNFα) by NF-κB, AP-1 and IRF5
  transcription factors and of IFN-I and IFN-III by IRF3 and IRF7 (left). IFNs act
  though transmembrane receptors to activate STAT1, STAT2 and IRF9. This complex then
  translocates to the nucleus to govern the expression of several interferon-stimulated
  genes (right), which mediate an antiviral state leading to cell apoptosis, cytostasis,
  antigen presentation and expression of viral restricting factors. Created with BioRender.com.
papertitle: 'Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation
  of Interferon Pathway in the Tumor Microenvironment.'
reftext: Glauco Akelinghton Freire Vitiello, et al. Front Immunol. 2021;12:782852.
year: '2021'
doi: 10.3389/fimmu.2021.782852
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: antiviral immune response | antitumor immunity | oncolytic viruses | interferons
  | epigenetic regulation | endogenous retroviral elements | immunotherapy
automl_pathway: 0.9282336
figid_alias: PMC8674309__F1
figtype: Figure
redirect_from: /figures/PMC8674309__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8674309__fimmu-12-782852-g001.html
  '@type': Dataset
  description: Activation of IFN-I/III response by viral sensing through PRRs. Sensing
    of viral molecules by plasma membrane (TRL4), endosomal (TLR3, 7, 8 and 9) or
    cytosolic (RLRs and cGAS) PRRs activate signaling pathways culminating in the
    expression of pro-inflammatory cytokines (IL-1β, IL-6, IL-18 and TNFα) by NF-κB,
    AP-1 and IRF5 transcription factors and of IFN-I and IFN-III by IRF3 and IRF7
    (left). IFNs act though transmembrane receptors to activate STAT1, STAT2 and IRF9.
    This complex then translocates to the nucleus to govern the expression of several
    interferon-stimulated genes (right), which mediate an antiviral state leading
    to cell apoptosis, cytostasis, antigen presentation and expression of viral restricting
    factors. Created with BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR2
  - TLR4
  - MYD88
  - IRAK4
  - IRAK1
  - IRAK2
  - JUN
  - TRAF6
  - TAB2
  - TAB3
  - IRF5
  - TLR9
  - TLR7
  - RELA
  - TLR3
  - TRAF3
  - RIGI
  - TBK1
  - IL1B
  - IL18
  - TNF
  - IL6
  - MAVS
  - IRF3
  - CGAS
  - IFNAR2
  - IRF9
  - STAT1
  - IFNAR1
  - TYK2
  - IL10RB
  - IFNLR1
  - STAT2
  - JAK1
  - Tlr2
  - Tlr4
  - Myd88
  - Irak4
  - Irak1
  - Irak2
  - Fos
  - Jun
  - Traf6
  - Tab2
  - Tab3
  - Nr2c2
  - Map3k7
  - Irf5
  - Tlr9
  - Tlr7
  - Rela
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Rnf138
  - Trim69
  - Ticam1
  - Ticam2
  - Tlr3
  - Ralbp1
  - Ripk1
  - Traf3
  - Ifih1
  - Rigi
  - Ikbke
  - Chuk
  - Tbk1
  - Ikbkb
  - Il1b
  - Il18
  - Tnf
  - Il6
  - Mavs
  - Irf3
  - Cgas
  - Sting1
  - Ifnar2
  - Irf9
  - Stat1
  - Ifnar1
  - Tyk2
  - Il10rb
  - Ifnlr1
  - Stat2
  - Jak1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - FOS
  - JUNB
  - JUND
  - FOSB
  - MAP3K7
  - NR2C2
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - TRIM69
  - TICAM1
  - UQCRFS1
  - RIPK1
  - RALBP1
  - KRR1
  - NFKB1
  - RELB
  - REL
  - NFKB2
  - IFIH1
  - IKBKG
  - IKBKE
  - CHUK
  - IKBKB
  - MTG1
  - ATP8A2
  - STING1
  - SOAT1
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - tlr2
  - myd88
  - irak4
  - irak1
  - jun
  - traf6
  - tab2
  - tab3
  - irf5
  - tlr9
  - tlr7
  - rela
  - nfkb1
  - ticam1
  - tlr3
  - ripk1l
  - traf3
  - pask
  - rigi
  - tbk1
  - il1b
  - tnfb
  - il6
  - mavs
  - irf3
  - cgasa
  - irf9
  - stat1a
  - stat1b
  - stat4
  - tyk2
  - il10rb
  - ifnlr1
  - stat2
  - ifnphi3
  - jak1
---
